{{knowledge objective
|Identifiant=OIC-036-08-B
|Item_parent=Contraception. (see item 330)
|Item_parent_short=Contraception. (see item 330)
|Rank=B
|Title=Know the criteria for choosing estroprogestogenic contraception as 1st line treatment.
|Description=None
|Heading=Management
|Contributors=Genevi√®ve Plu-Bureau
|Order=8}}
If there are no contraindications to the use of a COP and if the patient chooses an estroprogestative contraception, the recommendations are to prescribe a so-called 2nd<sup> generation</sup> contraception (containing EE and Levonorgestrel) or norgestimate (EE + norgestimate)''' given the lower vascular risk compared with all other combined contraceptions''''''